VEGF trap as a novel antiangiogenic treatment currently in clinical trials for cancer and eye diseases, and VelociGene- based discovery of the next generation of angiogenesis targets.
Saved in:
| Title: | VEGF trap as a novel antiangiogenic treatment currently in clinical trials for cancer and eye diseases, and VelociGene- based discovery of the next generation of angiogenesis targets. |
|---|---|
| Authors: | Rudge JS; Regneron Pharmaceuticals, Inc., Tarrytown, New York 10591, USA., Thurston G, Davis S, Papadopoulos N, Gale N, Wiegand SJ, Yancopoulos GD |
| Source: | Cold Spring Harbor symposia on quantitative biology [Cold Spring Harb Symp Quant Biol] 2005; Vol. 70, pp. 411-8. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cold Spring Harbor Laboratory Press Country of Publication: United States NLM ID: 1256107 Publication Model: Print Cited Medium: Print ISSN: 0091-7451 (Print) Linking ISSN: 00917451 NLM ISO Abbreviation: Cold Spring Harb Symp Quant Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
